It has been reported that Gpx1 protects against CD95-induced apoptosis in cultured breast cancer cells and inhibits 5-lipoxygenase in blood cells; overexpression delays endothelial cell growth and increases resistance to toxic challenge [39]. This evidence concerns the gene FAS and breast carcinoma.